AOD-9604 has no approved therapeutic dose, and the reason matters: its human obesity program did not establish an effective weight-loss dose in the first place. The compound is a fragment of human growth hormone (hGH 176-191), and its fat-oxidation effects come from mouse studies rather than positive human efficacy trials.[1][2]
Reviewed for accuracy · Last reviewed July 7, 2026Community protocols commonly cite around 300 mcg injected subcutaneously once daily, often before fasted cardio, but this is convention rather than a validated regimen. The pooled human data (six randomized, placebo-controlled trials, roughly 900 subjects) was collected to characterize safety, and it did not demonstrate meaningful weight loss, so no dose there can be called effective.
This page is an independent educational reference and is not medical advice, and does not indicate any approval status for any use. Talk to a doctor before starting any compound.